|
1
|
Pellicoro A, Ramachandran P, Iredale JP
and Fallowfield JA: Liver fibrosis and repair: Immune regulation of
wound healing in a solid organ. Nat Rev Immunol. 14:181–194. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Friedman SL: Mechanisms of hepatic
fibrogenesis. Gastroenterology. 134:1655–1669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sakurai T and Kudo M: Molecular link
between liver fibrosis and hepatocellular carcinoma. Liver Cancer.
2:365–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fausther M, Pritchard MT, Popov YV and
Bridle K: Contribution of liver nonparenchymal cells to hepatic
fibrosis: Interactions with the local microenvironment. Biomed Res
Int. 2017:68247622017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carnegie GK, Means CK and Scott JD:
A-kinase anchoring proteins: From protein complexes to physiology
and disease. IUBMB Life. 61:394–406. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poppinga WJ, Muñoz-Llancao P,
Gonzalez-Billault C and Schmidt M: A-kinase anchoring proteins:
cAMP compartmentalization in neurodegenerative and obstructive
pulmonary diseases. Br J Pharmacol. 171:5603–5623. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gelman IH: Suppression of tumor and
metastasis progression through the scaffolding functions of
SSeCKS/Gravin/AKAP12. Cancer Metastasis Rev. 31:493–500. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee SW, Kim WJ, Choi YK, Song HS, Son MJ,
Gelman IH, Kim YJ and Kim KW: SSeCKS regulates angiogenesis and
tight junction formation in blood-brain barrier. Nat Med.
9:900–906. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu W, Gong J, Hu J, Hu T, Sun Y, Du J,
Sun C, Guan M, Jiang H and Lu Y: Quantitative assessment of AKAP12
promoter methylation in human prostate cancer using
methylation-sensitive high-resolution melting: Correlation with
gleason score. Urology. 77(1006): e1–7. 2011.PubMed/NCBI
|
|
10
|
Akakura S, Huang C, Nelson PJ, Foster B
and Gelman IH: Loss of the SSeCKS/Gravin/AKAP12 gene results in
prostatic hyperplasia. Cancer Res. 68:5096–5103. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gelman IH: The role of
SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal
control of signaling pathways in oncogenesis and development. Front
Biosci. 7:d1782–d1797. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Choi MC, Jong HS, Kim TY, Song SH, Lee DS,
Lee JW, Kim TY, Kim NK and Bang YJ: AKAP12/Gravin is inactivated by
epigenetic mechanism in human gastric carcinoma and shows growth
suppressor activity. Oncogene. 23:7095–7103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia W, Unger P, Miller L, Nelson J and
Gelman IH: The Src-suppressed C kinase substrate, SSeCKS, is a
potential metastasis inhibitor in prostate cancer. Cancer Res.
61:5644–5651. 2001.PubMed/NCBI
|
|
14
|
Lin X and Gelman IH: Reexpression of the
major protein kinase C substrate, SSeCKS, suppresses v-src-induced
morphological transformation and tumorigenesis. Cancer Res.
57:2304–2312. 1997.PubMed/NCBI
|
|
15
|
Goeppert B, Schmezer P, Dutruel C, Oakes
C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi
A, et al: Down-regulation of tumor suppressor A kinase anchor
protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
Hepatology. 52:2023–2033. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hayashi M, Nomoto S, Kanda M, Okamura Y,
Nishikawa Y, Yamada S, Fujii T, Sugimoto H, Takeda S and Kodera Y:
Identification of the A kinase anchor protein 12 (AKAP12) gene as a
candidate tumor suppressor of hepatocellular carcinoma. J Surg
Oncol. 105:381–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xia W, Ni J, Zhuang J, Qian L, Wang P and
Wang J: MiR-103 regulates hepatocellular carcinoma growth by
targeting AKAP12. Int J Biochem Cell Biol. 71:1–11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu Y, Meyer C, Xu C, Weng H, Hellerbrand
C, ten Dijke P and Dooley S: Animal models of chronic liver
diseases. Am J Physiol Gastrointest Liver Physiol. 304:G449–G468.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wallace MC, Hamesch K, Lunova M, Kim Y,
Weiskirchen R, Strnad P and Friedman SL: Standard operating
procedures in experimental liver research: Thioacetamide model in
mice and rats. Lab Anim. 49 1 Suppl:S21–S29. 2015. View Article : Google Scholar
|
|
20
|
Abe M, Yoshida T, Akiba J, Ikezono Y, Wada
F, Masuda A, Sakaue T, Tanaka T, Iwamoto H, Nakamura T, et al:
STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary
proliferation in thioacetamide-induced liver injury. World J
Gastroenterol. 23:6833–6844. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hartig SM: Basic image analysis and
manipulation in ImageJ. Curr Protoc Mol Biol Chapter. 14:Unit14 15.
2013.doi: 10.1002/0471142727.mb1415s102. View Article : Google Scholar
|
|
22
|
Shin MW, Bae SJ, Wee HJ, Lee HJ, Ahn BJ,
Le H, Lee EJ, Kim RH, Lee HS, Seo JH, et al: Ninjurin1 regulates
lipopolysaccharide-induced inflammation through direct binding. Int
J Oncol. 48:821–828. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sakurai T, Yada N, Watanabe T, Arizumi T,
Hagiwara S, Ueshima K, Nishida N, Fujita J and Kudo M:
Cold-inducible RNA-binding protein promotes the development of
liver cancer. Cancer Sci. 106:352–358. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Helmy SA, El-Mesery M, El-Karef A, Eissa
LA and El Gayar AM: Chloroquine upregulates TRAIL/TRAILR2
expression and potentiates doxorubicin anti-tumor activity in
thioacetamide-induced hepatocellular carcinoma model. Chem Biol
Interact. 279:84–94. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Balkwill FR, Capasso M and Hagemann T: The
tumor microenvironment at a glance. J Cell Sci. 125:5591–5596.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hanahan D and Coussens LM: Accessories to
the crime: Functions of cells recruited to the tumor
microenvironment. Cancer Cell. 21:309–322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bussard KM, Mutkus L, Stumpf K,
Gomez-Manzano C and Marini FC: Tumor-associated stromal cells as
key contributors to the tumor microenvironment. Breast Cancer Res.
18:842016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Campbell I, Qiu W and Haviv I: Genetic
changes in tumour microenvironments. J Pathol. 223:450–458. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fukino K, Shen L, Patocs A, Mutter GL and
Eng C: Genomic instability within tumor stroma and
clinicopathological characteristics of sporadic primary invasive
breast carcinoma. JAMA. 297:2103–2111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wernert N, Löcherbach C, Wellmann A,
Behrens P and Hügel A: Presence of genetic alterations in
microdissected stroma of human colon and breast cancers. Anticancer
Res. 21:2259–2264. 2001.PubMed/NCBI
|
|
31
|
Arriazu E, de Galarreta Ruiz M, Cubero FJ,
Varela-Rey M, de Obanos Pérez MP, Leung TM, Lopategi A, Benedicto
A, Abraham-Enachescu I and Nieto N: Extracellular matrix and liver
disease. Antioxid Redox Signal. 21:1078–1097. 2014. View Article : Google Scholar : PubMed/NCBI
|
